Effects of dupilumab in type 1 neurofibromatosis coexisting with severe atopic dermatitis,

Effects of dupilumab in type 1 neurofibromatosis coexisting with severe atopic dermatitis,

Bibliographic Details
Main Authors:	Camilla Chello, Alvise Sernicola, Giovanni Paolino, Teresa Grieco
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Dermatologia 2021-10-01
Series:	Anais Brasileiros de Dermatologia
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962021000500638&tlng=en

Similar Items

Atopic Dermatitis and Ulcerative Colitis Successfully Treated with Upadacitinib
by: Teresa Grieco, et al.
Published: (2023-03-01)

Efficacy of dupilumab in moderate and severe atopic dermatitis
by: Stephan Weidinger, et al.
Published: (2023-06-01)

Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
by: Federica Gelato, et al.
Published: (2023-03-01)

Influence of dupilumab on the economic burden of severe asthma and atopic dermatitis
by: I. S. Krysanov, et al.
Published: (2020-09-01)

Treatment of Severe Atopic Dermatitis with Dupilumab in Patients with Advanced Cancer
by: Milena Tanczosova, et al.
Published: (2023-02-01)

Asthma improvement in patients treated with dupilumab for severe atopic dermatitis
by: Marco Dubini, et al.
Published: (2023-09-01)

Efficacy and safety of dupilumab in two adolescents with severe atopic dermatitis
by: Mara Giavina-Bianchi, et al.
Published: (2021-05-01)

Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
by: Maria Esposito, MD, et al.
Published: (2023-01-01)

Experience with dupilumab in patients with atopic dermatitis
by: E. A. Glukhova, et al.
Published: (2023-07-01)

Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
by: Silvia Ferrucci, et al.
Published: (2023-10-01)

Dupilumab in Children and Adolescents with Severe Atopic Dermatitis and Severe Asthma: A Case Series
by: Daniele Russo, et al.
Published: (2023-09-01)

Effect of Dupilumab on Sexual Desire in Adult Patients with Moderate to Severe Atopic Dermatitis
by: Maddalena Napolitano, et al.
Published: (2022-11-01)

Dupilumab for the treatment of moderate and severe atopic dermatitis: real-life experience
by: Jowita Sroka-Tomaszewska, et al.
Published: (2024-01-01)

Treatment of Severe Atopic Dermatitis with Dupilumab in Three Patients with Renal Diseases
by: Caterina Foti, et al.
Published: (2022-11-01)

Dupilumab for the treatment of adult atopic dermatitis in special populations
by: Cataldo Patruno, et al.
Published: (2022-10-01)

Is Dupilumab a chance for patients with moderate to severe atopic dermatitis? Literature review
by: Paweł Iwańczuk
Published: (2024-02-01)

Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate‐to‐severe atopic dermatitis
by: Delphine Staumont‐Sallé, et al.
Published: (2023-09-01)

Punctal stenosis associated with dupilumab therapy for atopic dermatitis
by: Debora H. Lee, et al.
Published: (2021-10-01)

Dupilumab in atopic dermatitis patients with chronic hepatitis B
by: Masako Matsutani, et al.
Published: (2022-04-01)

The application of the biological treatment in atopic dermatitis: focus on dupilumab
by: Yu. S. Smolkin, et al.
Published: (2023-03-01)

Uveitis and hypereosinophilia associated with dupilumab in an atopic dermatitis patient
by: Shiyu Zhang, et al.
Published: (2023-12-01)

Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study
by: Niccolò Gori, et al.
Published: (2023-12-01)

Dupilumab: Direct Cost and Clinical Evaluation in Patients with Atopic Dermatitis
by: Marco Ferrari, et al.
Published: (2023-01-01)

Retrospective Study of Dupilumab Treatment for Moderate to Severe Atopic Dermatitis in Korea: Efficacy and Safety of Dupilumab in Real-World Practice
by: Dong Hyek Jang, et al.
Published: (2020-06-01)

Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis
by: M. C. Fargnoli, et al.
Published: (2021-07-01)

[Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Italy]
by: Elena Galli, et al.
Published: (2022-06-01)

Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis
by: Andreas Wollenberg, et al.
Published: (2022-05-01)

Drug survival rate of dupilumab in Japanese patients with atopic dermatitis
by: Susumu Ichiyama, et al.
Published: (2021-10-01)

A Review of Dupilumab in the Treatment of Atopic Dermatitis in Infants and Children
by: Wang M, et al.
Published: (2024-03-01)

Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
by: Fabrizio Martora, et al.
Published: (2024-12-01)

Conjunctivitis as a common adverse effect of dupilumab in atopic dermatitis
by: Mikołaj Cichoń, et al.
Published: (2023-03-01)

Effectiveness of dupilumab for chronic prurigo in elderly patients with atopic dermatitis
by: Shinji Mitsuyama, et al.
Published: (2023-04-01)

Dupilumab for atopic dermatitis: what are patients learning on YouTube?
by: Deeti J. Pithadia, et al.
Published: (2022-01-01)

The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis
by: Lotte S. Spekhorst, et al.
Published: (2023-01-01)

Pharmacokinetics, pharmacodynamics, and exposure–efficacy of dupilumab in adults with atopic dermatitis
by: Mohamed A. Kamal, et al.
Published: (2022-10-01)

Effectiveness and safety of dupilumab in adults with moderate and severe atopic dermatitis in Colombia: Real-life experience
by: Julián Londoño, MD, et al.
Published: (2023-04-01)

Efficacy and safety of dupilumab in adult moderate-to-severe atopic dermatitis: An update narrative literature review
by: Magdalini Kreouzi, et al.
Published: (2022-01-01)

Psoriasis‐like eruptions developed in an atopic dermatitis patient treated with dupilumab
by: Rai Fujimoto, et al.
Published: (2022-12-01)

Real‐world use of dupilumab for 53 patients with atopic dermatitis in Japan
by: Masako Matsutani, et al.
Published: (2020-04-01)

Perception and Experience of Dupilumab in Atopic Dermatitis: A Real-Life Study
by: Antoine L, et al.
Published: (2023-09-01)